ZAG BIO
Live / Applied — Fourth extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 21 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97686797
- Mark type
- Stylized text
- Filed
- 21 Nov 2022
- Published for opposition
- 02 Jan 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of anti-drug immune responses; pharmaceutical preparations for the prevention of anti-drug immune responses; pharmaceutical preparations to inhibit rejection of transplanted organs and tissues; pharmaceutical preparations for the treatment of graft versus host disease
- Class 042 — Scientific and technological services: Pharmaceutical research services; pharmaceutical research and development; pharmaceutical drug development services; medical research; biomedical research services; medical and scientific research, namely, conducting clinical trials for others
Owner
- Zag Bio, Inc., Cambridge, MA, US
- Zag Bio, Inc., Cambridge, MA, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 4 GRANTED
- 24 Feb 2026 — SOU EXTENSION 4 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 3 GRANTED
- 12 Aug 2025 — SOU EXTENSION 3 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2025 — SOU EXTENSION 2 GRANTED
- 14 Feb 2025 — SOU EXTENSION 2 FILED
- 14 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jul 2024 — SOU EXTENSION 1 GRANTED
- 12 Jul 2024 — SOU EXTENSION 1 FILED